For people with type 2 diabetes, when pioglitazone and glipizide are given in doses sufficient to achieve equivalent glycemic control, pioglitazone increases total body water, thereby accounting for the majority of weight gain, and decreased visceral and abdominal fat content.
Read More »Mechanism For How The Pancreas Makes Insulin Is Crystalized
“It is possible that the insulin deficiency happens when the crystals don’t form properly and then part of the insulin that is produced gets destroyed.”
Read More »Clinical Screening Tool Developed for Identifying Type 1&1/2 Diabetes Adult Late
Clinical Screening Tool Developed for Identifying Type 1&1/2 Diabetes Adult Latent Autoimmune Diabetes The presence of 2 or more clinical risk factors for latent autoimmune diabetes in adults (LADA) may be useful for identifying adults at high risk for LADA who require islet antibody testing, a new report suggests.
Read More »New Diabetes Gene Discovered
Scientists have discovered a gene that plays a role in the most common type of type 2 diabetes, and they say the discovery could pave the way to a targeted treatment.
Read More »Genetic Epidemiology Of Diabetes
How many times do your patients ask you “is there a diabetes heredity” or “am I going to pass on the diabetes genes to my kids”. What do you tell them? Yes, No, or Maybe? What about all that stuff that says Type 1 is an autoimmune disease, does that …
Read More »Role of A Critical Visceral Adipose Tissue Threshold (CVATT) Part 6
Eric S. Freedland, MD, Boston University School of Medicine, explains the Implications of Controlling Dietary Carbohydrates and other methods to reduce VAT. In the final part of his groundbreaking series The Role Of A Critical Visceral Adipose Tissue Threshold (CVATT) In Metabolic Syndrome Role of A Critical Visceral Adipose Tissue …
Read More »Beta-Cell Dysfunction Implicated in Low Birth Weight-Related Diabetes
Findings from a study suggest that primary beta-cell dysfunction plays a key role in the pathogenesis of low birth weight (LBW)-associated type 2 diabetes.
Read More »Angiotensin Receptor Blockade Improves Renal Blood Flow in Diabetics
Chronic angiotensin II receptor blockade with olmesartan improves renal vascular perfusion despite significant blood pressure reductions in patients with type 2 diabetes.
Read More »Hemodynamic Risk Factors in the Development of Vision Threatening Diabetic Retin
Paul Chous, M.A., O.D. Doctor of Optometry Type 1 diabetic since 1968 Diabetic retinopathy is the leading cause of new blindness for persons under age 74 in the US. Recognized risk factors for the development and progression of diabetic retinopathy include disease duration, poor glycemic control, hypertension and disease sub-type. …
Read More »The Real Science of Hypoglycemia PART 2
Although hypoglycemia affects both types of diabetics, episodes are much more common and frequent in Type I diabetics. Hypoglycemia causes the body to respond with number of counterregulatory hormones.[i] [ii] Their most likely sequence of hormonal activation are glucagon, epinephrine and then if hypoglycemia is severe or prolonged cortisol and …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.